Fund moves
173KShares reported
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
WVE · NASDAQ · Pharmaceutical Preparations
$2.56−0.16 (−5.88%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Wave Life Sciences (WVE) · oqro.io/stocks/WVE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
No fund reported this stock
No mutual fund or ETF listed it in its latest public N-PORT report. Funds report each quarter, about two months after the quarter ends.
Institutions reporting a stake, Q2 2026
1
$2.49M reported in total
Share of stock reported
0.2%
429K of 197M shares outstanding
Change vs Q1 2026
+429K shares
1 new position, 0 positions closed
Reported in 13F filings, which cover managers over $100M and include double counting. A 13F shows holdings on the last day of the quarter, not when shares were bought or sold. Change counts the 1 managers that reported both quarters.
Source: SEC Form 13F data sets, every filer, common stock only (options and bonds left out). Amendments are applied; lines whose value was filed in thousands are scaled, and lines whose shares and value disagree are left out.